|
|
About the ACTU
- The
AIDS Clinical Trials Unit (ACTU) is part of a network of approximately
30 sites around the country that receive funding from the National
Institutes of Health to conduct research studies on HIV-related
treatments.
- The
focus of the ACTU is to study medicines which can fight HIV
infection and treat, or prevent, opportunistic infections associated
with HIV.
- Our
trials are open to participants with various stages of HIV infection,
those without symptoms and those with a diagnosis of AIDS.
- Your
involvement is important to HIV research. Information collected
on a study becomes part of a database that may eventually be
used to approve a drug.
- We
add new studies every few months as ongoing research suggests
promising new approaches.
|
- When
you first visit the ACTU, you are assigned a patient code. All
your lab results and blood specimens reported to the study database
is identified by your patient code, not by your name.
- All
identifying information is kept in locked files. Only personnel
involved in the study have access to this information.
- No
one can access this information without your permission.
- Your
name and the other information will be used to register you
at Bellevue Hospital as a clinic patient, in order to process
your routine non-HIV labs.
|
|
What
to expect when you first meet the research staff at NYUMC-Bellevue
|
- Your
first visit is usually with a screening nurse and lasts about
an hour.
- You
share information about your health and learn some key aspects
about studies (why some people go on studies, what an "informed"
consent is, the importance of maintaining your relationship
with your doctor or health care provider).
- There
is plenty of time for questions and it is also possible to return
to the clinic while deciding which study is best for you.
- Childcare
arrangements can be made prior to a scheduled appointment by
contacting the ACTU staff.
|
- Your
participation in the ACTU is not a replacement for your regular
medical care.
- Clients
enrolled in studies are required to have a primary care provider
and to see him/her for all issues not related to the study drug.
- The
clinician at the ACTU works with your health care provider.
We encourage you to discuss your intentions with your regular
provider, and to decide whether the risks of taking new drug(s)
are in your best interest.
- Some
issues to consider are: the frequency of visits, length of the
study, and the number of medications required and how participation
will impact your lifestyle.
- With
your permission, study specific lab results are regularly forwarded
to your provider to prevent duplication of tests as well as
to keep him/her informed.
|
|